AI assistant
SIGA TECHNOLOGIES INC — Director's Dealing 2017
Jun 12, 2017
32600_dirs_2017-06-12_335557b6-6995-46b4-9083-877fd65ae162.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SIGA TECHNOLOGIES INC (SIGA)
CIK: 0001010086
Period of Report: 2017-06-08
Reporting Person: Hruby Dennis E (N/A)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-06-08 | Stock Option (Right to buy) | $3.1 | D | 200000 | Disposed | 2017-07-26 | Common Stock, par value $.0001 per share (200000) | Direct |
| 2017-06-08 | Restricted Stock Units | $ | A | 25000 | Acquired | Common Stock, par value $.0001 per share (25000) | Direct |
Footnotes
F1: Options to purchase up to 300,000 shares of common stock of SIGA Technologies, Inc. (the "Issuer") were granted to the reporting person pursuant to a Stock Option Agreement, dated July 26, 2007, of which options to purchase 200,000 of such shares have vested.
F2: The 200,000 vested options were cash settled by mutual agreement of the reporting person and the Issuer. The reporting person received $84,000 as consideration for the surrender and cancellation of the vested options.
F3: Each restricted stock unit ("RSU") converts into one share of common stock of the Issuer on a one for one basis.
F4: The RSUs vest upon the U.S. Food & Drug Administration's final approval of TPOXX for the treatment of orthopoxvirus infections.